Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . (CORE-HIV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02003703
Recruitment Status : Recruiting
First Posted : December 6, 2013
Last Update Posted : December 12, 2017
Roche Pharma AG
Aclin Laboratories, Chile
Information provided by (Responsible Party):
Felipe Martinez, Universidad de Valparaiso

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2018
  Study Completion Date : No date given